Researchers from the University of Cambridge and the NIHR Cambridge Biomedical Research Centre have created an algorithm that finds vulnerable cancer tumours.
The defect that causes Huntington's disease has been corrected in patients for the first time with an experimental drug
Experts believe that the new experimental drug, which...